Simultaneous identification of GSTP1 Ile105 -> Val105 and Ala114 -> Val114substitutions using an amplification refractory mutation system polymerasechain reaction assay: studies in patients with asthma
A. Hemmingsen et al., Simultaneous identification of GSTP1 Ile105 -> Val105 and Ala114 -> Val114substitutions using an amplification refractory mutation system polymerasechain reaction assay: studies in patients with asthma, RESPIR RES, 2(4), 2001, pp. 250-255
Background: The glutathione S-transferase (GST) enzyme GSTP1 utilizes bypro
ducts of oxidative stress. We previously showed that alleles of GSTP1 that
encode the Ile105 --> Val105 substitution are associated with the asthma ph
enotypes of atopy and bronchial hyperresponsiveness (BHR). However, a furth
er polymorphic site (Ala114 --> Val114) has been identified that results in
the following alleles: GSTP1*A (wild-type Ile105 --> Ala114), GSTP1*B (Val
105 --> Ala114), GSTP1*C (Val105 --> Val114) and GSTP1*D (Ile105 --> Val114
).
Methods: Because full identification of GSTP1 alleles may identify stronger
links with asthma phenotypes, we describe an amplification refractory muta
tion system (ARMS) assay that allows identification of all genotypes. We ex
plored whether the GSTP1 substitutions influence susceptibility to asthma,
atopy and BHR.
Results: Among 191 atopic nonasthmatic, atopic asthmatic and nonatopic nona
sthmatic individuals, none had the BD, CD, or DD genotypes. GSTP1 BC was si
gnificantly associated with reduced risk for atopy (P = 0.031). Compared wi
th AA, trend test analysis identified a significant decrease in the frequen
cy of GSTP1 BC with increasing severity of BHR (P = 0.031). Similarly, the
frequency of GSTP1 AA increased with increasing BHR.
Conclusion: These data suggest that GSTP1*B and possibly GSTP1*C are protec
tive against asthma and related phenotypes.